TITLE

Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India

AUTHOR(S)
Tripathy, S.; Anand, A.; Inamdar, V.; Manoj, M. M.; Khillare, K. M.; Datye, A. S.; Iyer, R.; Kanoj, D. M.; Thakar, M.; Kale, V.; Pereira, M.; Risbud, A. R.
PUB. DATE
May 2011
SOURCE
Indian Journal of Medical Research;May2011, Vol. 133 Issue 5, p521
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background & objectives: in the Revised National Tuberculosis Control Programme (RNTCP) in India prior to 2005, TB patients were offered standard DOTS regimens without knowledge of HIV status. Consequently such patients did not receive anti-retroviral therapy (ART) and the influence of concomitant HIV infection on the outcome of anti-tuberculosis treatment remained undetermined. This study was conducted to determine the results of treatment of HIV seropositive pulmonary tuberculosis patients with the RNTCP (DOTS) regimens under the programme in comparison with HIV negative patients prior to the availability, of free ART in India. Methods: Between September 2000 and July 2006, 283 newly diagnosed pulmonary TB patients were enrolled in the study at the TB Outpatient Department at the Talera Hospital in the Pimpri Chinchwad Municipal Corporation area at Pune (Maharashtra): they included 121 HIV seropositive and 162 HIV seronegative patients. They were treated for tuberculosis as per the RNTCP in India. This study was predominantly conducted in the period before the free ART become available in Pune. Results: At the end of 6 months of anti-TB treatment, 62 per cent of the HIV seropositive and 92 per cent of the HIV negative smear negative patients completed treatment and were asymptomatic; among smear positive patients, 70 per cent of the HIV-seropositive and 81 per cent of HIV seronegative pulmonary TB patients were cured. Considering the results in the smear positive and smear negative cases together, treatment success rates were substantially lower in HIV positive patients than in HIV negative patients, (66% vs 85%). Further, 29 per cent of HIV seropositive and 1 per cent of the HIV seronegative patients expired during treatment. During the entire period of 30 months, including 6 months of treatment and 24 months of follow up, 61 (51%) of 121 HIV positive patients died; correspondingly there were 6 (4%) deaths among HIV negative patients. Interpretation & conclusions: The HIV seropositive TB patients responded poorly to the RNTCP regimens as evidenced by lower success rates with chemotherapy and high mortality rates during treatment and follow up. There is a need to streamline the identification and management of HIV associated TB patients in the programme with provision of ART to achieve high cure rates for TB, reducing mortality rates and ensuring a better quality of life.
ACCESSION #
61905857

 

Related Articles

  • Development of Opportunistic Infections After Diagnosis of Active Tuberculosis in HIV-Infected Patients. Kwara, Awewura; Carter, E. Jane; Rich, Josiah D.; Flanigan, Timothy P. // AIDS Patient Care & STDs;Jun2004, Vol. 18 Issue 6, p341 

    Despite advances in highly active antiretroviral therapy (HAART), its use during tuberculosis (TB) treatment is fraught with challenges, often leading to delayed therapy. This report describes the course of HIV infection and outcomes of 26 consecutive TB/HIV coinfected patients who received TB...

  • Issues in Correctional HIV Care: Treatment of Tuberculosis. Macher, Abe // American Jails;Jan/Feb2005, Vol. 18 Issue 6, p25 

    Discusses specific treatment considerations for patients with HIV-infection and tuberculosis (TB) in the U.S. Total number of TB cases in the country; Use of antiretroviral drugs in patients with concomitant TB; Association of all antiretroviral drugs with the potential for hepatotoxicity.

  • HIV Testing and Treatment Among Tuberculosis Patients -- Kenya, 2006-2009. Sitienei, J.; Kipruto, H.; Nganga, L.; Ackers, M.; Odhiambo, J.; Laserson, K.; Nakashima, A. K.; Modi, S. // MMWR: Morbidity & Mortality Weekly Report;11/26/2010, Vol. 59 Issue 46, p1514 

    The article discusses a report on HIV data from Kenya's tuberculosis (TB) surveillance system from 2006 to 2009. The Kenya Division of Leprosy, Tuberculosis and Lung Disease (DLTLD) added HIV testing and treatment to its TB surveillance program at the recommendation of the World Health...

  • Adverse events and treatment interruption in tuberculosis patients with and without HIV co- infection. Breen, R. A. M.; Miller, R. F.; Gorsuch, T.; Smith, C. J.; Schwenk, A.; Holmes, W.; Ballinger, J.; Swaden, L.; Johnson, M. A.; Cropley, I.; Lipman, M. C. I. // Thorax;Sep2006, Vol. 61 Issue 9, p791 

    Background: Serious treatment associated adverse events are thought to occur more frequently in individuals with tuberculosis (TB) who are co-infected with HIV. A study was undertaken to assess the frequency of serious (grade Ill/IV) adverse events and interruption of anti-TB treatment in the...

  • Timing, rates, and causes of death in a large South African tuberculosis programme. Field, Nigel; Lim, Megan S. C.; Murray, Jill; Dowdeswell, Robert J.; Glynn, Judith R.; Sonnenberg, Pam // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background: Tuberculosis (TB) mortality remains high across sub-Saharan Africa despite integration of TB and HIV/ART programmes. To inform programme design and service delivery, we estimated mortality by time from starting TB treatment. Methods: Routinely collected data on TB treatment, vital...

  • Intensive Tuberculosis Screening for HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa. Bassett, Ingrid V.; Wang, Bingxia; Chetty, Senica; Giddy, Janet; Losina, Elena; Mazibuko, Matilda; Bearnot, Benjamin; Allen, Jenny; Walensky, Rochelle P.; Freedberg, Kenneth A. // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p823 

    Background. The World Health Organization (WHO) recommends cough as the trigger for tuberculosis screening in human immunodeficiency virus (HIV)-infected patients, with acid-fast bacillus (AFB) smear as the initial diagnostic test. Our objective was to assess the yield and cost of a more...

  • Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa. Uyei, Jennifer; Coetzee, David; Macinko, James; Weinberg, Sharon L; Guttmacher, Sally // Health Policy & Planning;Jan2014, Vol. 29 Issue 1, p42 

    To address the considerable tuberculosis (TB)/HIV co-infected population in Cape Town, a number of clinics have made an effort of varying degrees to integrate TB and HIV services. This article describes the development of a theory-based survey instrument designed to quantify the extent to which...

  • ART during TB treatment saves lives at acceptable costs in SA.  // PharmacoEconomics & Outcomes News;Aug2015, Vol. 733 Issue 1, p8 

    The article reports on a study, published in the "Journal of Acquired Immune Deficiency Syndromes," which found that antiretroviral therapy (ART) during tuberculosis treatment in HIV-TB co-infected patients in South Africa is cost-effective and saves lives.

  • Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis Suthar, Amitabh B.; Lawn, Stephen D.; del Amo, Julia; Getahun, Haileyesus; Dye, Christopher; Sculier, Delphine; Sterling, Timothy R.; Chaisson, Richard E.; Williams, Brian G.; Harries, Anthony D.; Granich, Reuben M. // PLoS Clinical Trials;Jul2012, Vol. 7 Issue 7, p1 

    In a systematic review and meta-analysis, Amitabh Suthar and colleagues investigate the association between antiretroviral therapy and the reduction in the incidence of tuberculosis in adults with HIV infection.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics